entertainment -WSS

entertainment

author：leisure time 2025-10-01 00:47:45 - browse：21

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Wikipedia

hotspot

WSS

How the Dana

Lupron, used to halt puberty in children, may cause lasting health problems

Address the ethical violations that led to 'Three Identical Strangers'

After a drawn out lobbying fight, ARPA

Canadians with cystic fibrosis outlive Americans by a decade

A letter from the executive editor: The 2023 STATUS List

hotspot

entertainment

knowledge

In Memoriam: Notable people who died in 2023

Inequities make cancer less preventable for women: report

In age of alternative facts, a scholarly course on calling out crap

After a drawn out lobbying fight, ARPA

Walensky prepares to leave CDC — and Congress — behind

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Tori Bowie and the unacceptable rates of Black maternal death

Listen: Who gets the credit for GLP

Tori Bowie and the unacceptable rates of Black maternal death

Security flaws in third

entertainment

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Fatty liver disease was alleviated by Lilly’s ‘triple

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

The wait for US passports is creating travel purgatory and snarling summer plans

Crowdfunding for unproven stem cell procedures spreads misinformation

Wikipedia

knowledge

hotspot

focus